CBKM — what changed in the latest 10-Q
A section-by-section comparison of CBKM's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-08 vs the prior 10-Q · 2026-02-06
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +15 | −16 | ~54 | 122 |
| Controls & procedures | Text added/removed | +15 | −16 | ~54 | 122 |
| Legal proceedings | Text added/removed | +15 | −16 | ~54 | 122 |
| Other information | Text added/removed | +15 | −16 | ~54 | 121 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Market risk (Item 3), Risk factors
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-08
Vesting of 4,602 shares associated with restricted stock awards
Vesting of 8,159 shares associated with restricted stock awards
Unrealized holding losses on available-for-sale securities arising during the period
Net income for the third quarter of fiscal year 2026 was $2,817, or $0.90 per common share, compared with $1,851, or $0.59 per common share for the three months ended March 31, 2025. The following are key highlights of our results of operations for the three months ended March 31, 2026, compared wit…
tax-equivalent net interest income increased by $1,556, or 18.0%, to $10,212 in the third quarter of fiscal year 2026 from the same prior year period primarily because of a $109,485, or 10.5%, increase in average interest- earning assets combined with a 28-basis point increase in the yield on intere…
Text removed vs the prior filing · source: 10-Q · 2026-02-06
Issuance of 3,905 shares associated with dividend reinvestment plan and stock purchase plan
Amounts reclassified from accumulated other comprehensive gains
Unrealized holding losses on available-for-sale securities arising during the period
Three- and Six- Month Periods Ended December 31, 2025 and 2024
Net income for the second quarter of fiscal year 2026 was $2,755, or $0.87 per common share, compared with $2,287, or $0.73 per common share for the three months ended December 31, 2024. The following are key highlights of our results of operations for the three months ended December 31, 2025, compa…
Controls & procedures
Text added vs the prior filing · source: 10-Q · 2026-05-08
Vesting of 4,602 shares associated with restricted stock awards
Vesting of 8,159 shares associated with restricted stock awards
Unrealized holding losses on available-for-sale securities arising during the period
Net income for the third quarter of fiscal year 2026 was $2,817, or $0.90 per common share, compared with $1,851, or $0.59 per common share for the three months ended March 31, 2025. The following are key highlights of our results of operations for the three months ended March 31, 2026, compared wit…
tax-equivalent net interest income increased by $1,556, or 18.0%, to $10,212 in the third quarter of fiscal year 2026 from the same prior year period primarily because of a $109,485, or 10.5%, increase in average interest- earning assets combined with a 28-basis point increase in the yield on intere…
Text removed vs the prior filing · source: 10-Q · 2026-02-06
Issuance of 3,905 shares associated with dividend reinvestment plan and stock purchase plan
Amounts reclassified from accumulated other comprehensive gains
Unrealized holding losses on available-for-sale securities arising during the period
Three- and Six- Month Periods Ended December 31, 2025 and 2024
Net income for the second quarter of fiscal year 2026 was $2,755, or $0.87 per common share, compared with $2,287, or $0.73 per common share for the three months ended December 31, 2024. The following are key highlights of our results of operations for the three months ended December 31, 2025, compa…
Legal proceedings
Text added vs the prior filing · source: 10-Q · 2026-05-08
Vesting of 4,602 shares associated with restricted stock awards
Vesting of 8,159 shares associated with restricted stock awards
Unrealized holding losses on available-for-sale securities arising during the period
Net income for the third quarter of fiscal year 2026 was $2,817, or $0.90 per common share, compared with $1,851, or $0.59 per common share for the three months ended March 31, 2025. The following are key highlights of our results of operations for the three months ended March 31, 2026, compared wit…
tax-equivalent net interest income increased by $1,556, or 18.0%, to $10,212 in the third quarter of fiscal year 2026 from the same prior year period primarily because of a $109,485, or 10.5%, increase in average interest- earning assets combined with a 28-basis point increase in the yield on intere…
Text removed vs the prior filing · source: 10-Q · 2026-02-06
Issuance of 3,905 shares associated with dividend reinvestment plan and stock purchase plan
Amounts reclassified from accumulated other comprehensive gains
Unrealized holding losses on available-for-sale securities arising during the period
Three- and Six- Month Periods Ended December 31, 2025 and 2024
Net income for the second quarter of fiscal year 2026 was $2,755, or $0.87 per common share, compared with $2,287, or $0.73 per common share for the three months ended December 31, 2024. The following are key highlights of our results of operations for the three months ended December 31, 2025, compa…
Other information
Text added vs the prior filing · source: 10-Q · 2026-05-08
Vesting of 4,602 shares associated with restricted stock awards
Vesting of 8,159 shares associated with restricted stock awards
Unrealized holding losses on available-for-sale securities arising during the period
Net income for the third quarter of fiscal year 2026 was $2,817, or $0.90 per common share, compared with $1,851, or $0.59 per common share for the three months ended March 31, 2025. The following are key highlights of our results of operations for the three months ended March 31, 2026, compared wit…
tax-equivalent net interest income increased by $1,556, or 18.0%, to $10,212 in the third quarter of fiscal year 2026 from the same prior year period primarily because of a $109,485, or 10.5%, increase in average interest- earning assets combined with a 28-basis point increase in the yield on intere…
Text removed vs the prior filing · source: 10-Q · 2026-02-06
Issuance of 3,905 shares associated with dividend reinvestment plan and stock purchase plan
Amounts reclassified from accumulated other comprehensive gains
Unrealized holding losses on available-for-sale securities arising during the period
Three- and Six- Month Periods Ended December 31, 2025 and 2024
Net income for the second quarter of fiscal year 2026 was $2,755, or $0.87 per common share, compared with $2,287, or $0.73 per common share for the three months ended December 31, 2024. The following are key highlights of our results of operations for the three months ended December 31, 2025, compa…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice